MODUCARE COMBINATION PRODUCT CAPSULE

Indications

• Hyperlipidemia
• Benign prostatic hyperplasia (BPH)
• Cholesterol management

Dosage

Children: Refer to BNF for Children for specific paediatric dosing information.

Adults: Refer to BNF for specific dosing recommendations, as they may vary based on the condition being treated and formulation used.

Mechanism of action

Beta-sitosterol exerts its effects by inhibiting the absorption of cholesterol in the intestines. It competes with cholesterol for intestinal uptake, leading to decreased levels of serum cholesterol. Additionally, it may influence the metabolism of steroids and other lipids through pathways involved in steroid biosynthesis and degradation, as evidenced by its association with the plant sterol biosynthesis pathway.

Pharmacodynamics

Beta-sitosterol is absorbed in the gastrointestinal tract and may lead to a slight reduction in serum cholesterol levels. Its phytosterolic structure allows it to mimic cholesterol, which aids in its absorption competitive action. Furthermore, it may have anti-inflammatory properties, which can contribute to its therapeutic effects in conditions like BPH and cholesterol management.

Pharmacokinetics

Beta-sitosterol is absorbed from the gastrointestinal tract, but its bioavailability is relatively low due to its poor solubility. The compound is metabolized in the liver and excreted in bile and urine. Its half-life and excretion details may vary based on individual metabolic processes.

Pregnancy

There is insufficient data on the use of betasitosterol during pregnancy. It is advised to consult healthcare professionals before use.

Breast-feeding

Limited data is available regarding the use of betasitosterol during breastfeeding. Caution is recommended, and consulting with a healthcare provider is advisable.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.